Pascal is the founder and CEO of Genoskin (https://www.genoskin.com/), a biotech company based in the US and in France, which recycles donated excess human skin samples into reliable ex vivo human skin models to test the efficacy and toxicity of drugs, actives, chemicals and medical devices. Genoskin's products are also alternatives to animal testing.
Before launching Genoskin, Pascal acquired over 15 years of experience in research on the development and characterization of pathological skin models. He holds a PhD degree in Pathophysiology from the University of Toulouse, France. He also holds Master’s Degree in Management from the Toulouse Business School.